Please use this identifier to cite or link to this item:
http://111.93.178.142:25000/jspui/handle/123456789/5003Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Jamal Lasri | - |
| dc.date.accessioned | 2026-05-30T14:51:24Z | - |
| dc.date.available | 2026-05-30T14:51:24Z | - |
| dc.date.issued | 2026-05-30 | - |
| dc.identifier.uri | http://111.93.178.142:25000/jspui/handle/123456789/5003 | - |
| dc.description | Vol. 65, No. 4, p 299 | en_US |
| dc.language.iso | en | en_US |
| dc.subject | (Z) Ferrocenecarboxaldehyde aldoxime | en_US |
| dc.subject | (E) Ferrocene based aldimine | en_US |
| dc.subject | Hirshfeld | en_US |
| dc.subject | Anticancer | en_US |
| dc.subject | Molecular docking | en_US |
| dc.title | Hirshfeld analysis, anticancer efficacy and molecular docking studies for ferrocecarboxaldehyde oxime and ferrocene based aldimine | en_US |
| dc.type | Other | en_US |
| Appears in Collections: | Vol. 65 No.4, 2026 | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 1.pdf | Vol. 65, No. 4, p 299 | 148.5 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.